STA Compact Max®, the new generation Stago analyser, delivers accurate and timely answers to clinicians while helping laboratories to cope with economic and functional challenges by improving efficiency both operationally and environmentally. Its reliability enables this multiparametric system to operate optimally in every situation, including in highly demanding environments in terms of workload and volume testing. Its ergonomic and graphical user interface ensures a seamless integration in the lab. Furthermore, the new additional expert module will provide standardized results with fast turnaround time. Designed for mid-volume throughput laboratories, the instrument is suitable for routine and specialty assays. It offers viscosity-based (mechanical) detection system for clotting assay, chromogenic and immunological testing, extended sample, reagent and disposable loading capacities, true STAT management and high traceability. A wide range of dedicated reagents, quality controls and calibrators is available.
Read more

Designed for daily use in small labs and providing all the qualities of a high throughput qualitative instrument at an affordable rate, the ZENIX 2200 features a high quality optical system, using semi-reflective mirrors and cuvettes with excellent UV penetrability for the same level of sensitivity as the best systems on the market. Efficiency is increased thanks to its independent washing station, 44 reagent and 44 sample capacity rotors and its comprehensive software compatible with Windows® 7, Vista and XP. With a throughput of 200 tests/hour, the instrument also uses automatic dilution and retesting when concentrations are outside limits. Its maintenance-free micro pump and easy access to internal systems optimize maintenance and allow for quick and easy servicing.
Read more

Designed for the measurement of AIF-1 in human serum and plasma, the innovative AIF-1 ELISA is suitable for the determination of a novel biomarker relevant particularly to the risk of transplant rejection or vasculopathy and graft versus host disease. Allograft inflammatory factor-1 (AIF-1) is an interferon gamma-inducible cytoplasmic protein constitutively expressed in inflammatory cells and inducible in vascular smooth muscle cells in response to injury or inflammatory stimuli, including rejection or balloon angioplasty. Its expression correlates with cardiac rejection and the development of cardiac allograft vasculopathy. AIF-1 expression levels and protein concentrations were also studied in atherosclerosis, nephritis, arthritis, breast cancer and others. The BioVendor assay meets all the requirements for the routine clinical use in manual manner as well as on open ELISA robotic systems.
Read more

Testing for protein S plays an important role in thrombophilia screening. The INNOVANCE® Free PS Ag (protein S antigen) assay employs polystyrene particles coated with monoclonal antibodies for highly specific determination of free protein S. The assay demonstrates high linearity and excellent precision over the entire calibrated measuring range, as well as high specificity for free protein S antigens with no major interferences, including those commonly incurred from rheumatoid factors and heterophilic antibodies. The test delivers excellent reagent stability, superb lot-to-lot consistency and correlation of results among all the coagulation analysers on which it runs. The test’s ease of use minimizes operator training, and the liquid formulation requires no mixing or preparation, loading easily onto coagulation analysers.
Read more

SkanSmart promises to accelerate uptake of POC in the field testing, as well as hospital, clinic and doctors office settings, since its proprietary soft ware platform enables rapid handheld reading of existing commercially available flow assay formats. Utilizing Skannex patented image analysis and barcode software technology, users read simple yes/no, semi or fully quantitative results. Results can be printed wirelessly, emailed or downloaded to HIS systems. Infectious Disease, STD and Drugs of Abuse testing are immediate potential beneficiaries. Skannex has already introduced a series of well-received desktop readers over the last 3 years, including SkanMulti and SkanFlexi. The company aims to market the device to lateral flow manufacturing companies, providing a portable device for their proprietary assays.
Read more